Search results

Lunds universitet 1 Jämställdhets- och likabehandlingsplan för Institutionen för naturgeografi och ekosystemvetenskap avseende perioden oktober 2015 till december 2016 fastställd vid styrelsemöte 2015-10-08. Diskrimineringslag (2008:567) Lagens ändamål Kap 1, 1 § Denna lag har till ändamål att motverka diskriminering och på andra sätt främja lika rättigheter och möjligheter oavsett kön, könsöversk

https://www.nateko.lu.se/sv/sites/nateko.lu.se.sv/files/jamstalldhetsplan2015_naturgeografi.pdf - 2025-11-14

LUNDS UNIVERSITET Sida 1 av 5 PROTO KOLL CAMPUS HELSINGBORG Samrnantradesdatum 2023-05-09 Diarienummer STYR 2023/1082 U tveckl i ng sen heten Protokoll Campus Helsingborgs styrelse Narvarande ledamoter Lena Eski lsson Charlotta Johnsson Christofer Edling Annika Olsson, digitalt Patrik Lindskoug Kristina Akesson, digitalt, lamnade vid punkt 8. Olof Sundin, digitalt Mattias Wengelin, digitalt, lamna

https://www.ch.lu.se/internt/sites/ch.lu.se.internt/files/2023-11/Styrelsen%202023-05-09%20protokoll.pdf - 2025-11-14

Utmaningar och möjligheter vid renovering av våtrum A N D E R S J A N S S O N O C H U L F A N T O N S S O N Rapport nr 2015:2 U t m a n i n g a r o c h m ö j l i g h e t e r v i d r e n o v e r i n g a v v å t r u m 2 U t m a n i n g a r o c h m ö j l i g h e t e r v i d r e n o v e r i n g a v v å t r u m 3 Utmaningar och möjligheter vid renovering av våtrum Ulf Antonsson och Anders Jansson Susta

https://www.renoveringscentrum.lth.se/sites/renoveringscentrum.lth.se/files/2025-09/2015_2_Utmaningar_och_-_vaatrum_2015-09-24_Slutligversion.pdf - 2025-11-14

Utlysning av universitetsgemensamma medel – Tvärvetenskapliga projekt med fokus på Agenda 2030 och hållbar utveckling 1 Forskningsnämnden UTLYSNING 20210315 STYR 2021/682 Utlysning av universitetsgemensamma medel – Tvärvetenskapliga projekt med fokus på Agenda 2030 och hållbar utveckling Syfte och mål Lunds universitet avsätter upp till 100 mnkr till en universitetsgemensam satsning på excellens v

https://www.medarbetarwebben.lu.se/sites/medarbetarwebben.lu.se/files/2021-03/Utlysning%20slutlig%20SVE_0.pdf - 2025-11-14

Årsrapport 2004 för Enheten för medicinens historia, Medicinska Fakulteten, Lunds universitet 1 Årsrapport 2023 för Enheten för medicinens historia, Medicinska Fakulteten, Lunds universitet Enheten för medicinens historia har under året 2023 fortsatt sin verksamhet som en fristående enhet inom Institutionen för kliniska vetenskaper (IKVL) i Lund (prefekt Mikael Bodelsson), tillhörande sektion 5. E

https://www.medicinhistoria.lu.se/sites/medicinhistoria.lu.se/files/2024-01/Arsrapport_MH_FINAL_2023_1.pdf - 2025-11-14

Lägg till titel Sida 1 av 5 Dekan REMISSYTTRANDE Diarienummer V 2025/619 Datum 2025-06-03 Utbildningsdepartementet Yttrande för remissen: En socionomutbildning i tiden (SOU 2025:27) U2025/00722 Samhällsvetenskapliga fakulteten vid Lunds universitet, som anmodats att yttra sig över rubricerade remiss, avger följande yttrande. Yttrandet har utarbetats av Björn Johnson, professor, Lotta Jägervi, fil

https://www.sam.lu.se/sites/sam.lu.se/files/2025-11/U2025-00722_Lunds%20uni_SamFak_yttrande_SOU%202025-27_Socionomutbildning_V%202025-619.pdf - 2025-11-14

Microsoft Word - HILMA 2007-12-19.doc HILMA Historiska Institutionen i Lund Meddelar Att… Årgång 33, 2007/08, Nr 7, 2007-12-19 Underlagen till HILMA förvaras i pärmar som står i rum 209, på hyllan ovanför faxen. Där hittar du ytterligare information om seminarier, anställningsvillkor, stipendier och annat samt ansök- ningsblanketter i förekommande fall. De sistnämnda, som är samlade i en separat p

https://www.hist.lu.se/fileadmin/_migrated/content_uploads/hilma_ht07_7_03.pdf - 2025-11-13

Allergic immunity is orchestrated by group 2 innate lymphoid cells (ILC2s) and type 2 helper T (Th2) cells prominently arrayed at epithelial- and microbial-rich barriers. However, ILC2s and Th2 cells are also present in fibroblast-rich niches within the adventitial layer of larger vessels and similar boundary structures in sterile deep tissues, and it remains unclear whether they undergo dynamic r

Introduction: Reporting of hypoglycaemia and its impact in clinical studies is often retrospective and subject to recall bias. We developed the Hypo-METRICS app to measure the daily physical, psychological, and social impact of hypoglycaemia in adults with type 1 and insulin-treated type 2 diabetes in real-time using ecological momentary assessment (EMA). To help assess its utility, we aimed to de

Acute myeloid leukemia with t(6; 9)(p22; q34) is listed as a distinct entity in the 2008 World Health Organization classification, but little is known about the clinical implications of t(6; 9)-positive myeloid leukemia in children. This international multicenter study presents the clinical and genetic characteristics of 62 pediatric patients with t(6; 9)/DEKNUP214-rearranged myeloid leukemia; 54

Anemia because of insufficient production of and/or response to erythropoietin (Epo) is a major complication of chronic kidney disease and cancer. The mechanisms modulating the sensitivity of erythroblasts to Epo remain poorly understood. We show that, when cultured with Epo at suboptimal concentrations, the growth and clonogenic potential of erythroblasts was rescued by transferrin receptor 1 (Tf

Maturity-onset diabetes of the young (MODY) is a heterogeneous single gene disorder characterized by non–insulin-dependent diabetes, an early onset and autosomal dominant inheritance. Mutations in six genes have been shown to cause MODY. Approximately 15–20% of families fitting MODY criteria do not have mutations in any of the known genes. These families provide a rich resource for the identificat

Hypomethylating agents (HMAs) are frontline therapies for Myelodysplastic Neoplasms (MDS) and Acute Myeloid Leukemia (AML). However, acquired resistance and treatment failure are commonplace. To address this, we perform a genome-wide CRISPR-Cas9 screen in a human MDS-derived cell line, MDS-L, and identify TOPORS as a loss-of-function target that synergizes with HMAs, reducing leukemic burden and i

Background Although human leukocyte antigen (HLA) DQ and DR loci appear to confer the strongest genetic risk for type 1 diabetes, more detailed information is required for other loci within the HLA region to understand causality and stratify additional risk factors. The Type 1 Diabetes Genetics Consortium (T1DGC) study design included high-resolution genotyping of HLA-A, B, C, DRB1, DQ, and DP loc

BACKGROUND Nivolumab was associated with higher rates of objective response than chemotherapy in a phase 3 study involving patients with ipilimumab-refractory metastatic melanoma. The use of nivolumab in previously untreated patients with advanced melanoma has not been tested in a phase 3 controlled study. METHODS We randomly assigned 418 previously untreated patients who had metastatic melanoma w

Aims/hypothesis: The aim of this work was to examine the impact of hypoglycaemia on daily functioning among adults with type 1 diabetes or insulin-treated type 2 diabetes, using the novel Hypo-METRICS app. Methods: For 70 consecutive days, 594 adults (type 1 diabetes, n=274; type 2 diabetes, n=320) completed brief morning and evening Hypo-METRICS ‘check-ins’ about their experienced hypoglycaemia a

Purpose: To compare rates of tau biomarker positivity (T-status) per the 2018 Alzheimer’s Disease (AD) Research Framework derived from [18F]flortaucipir (FTP) PET visual assessment, FTP quantification, and cerebrospinal fluid (CSF) phosphorylated Tau-181 (PTau181). Methods: We included 351 subjects with varying clinical diagnoses from three cohorts with available FTP PET and CSF PTau181 within 18

Swelling of the brain or spinal cord (CNS edema) affects millions of people every year. All potential pharmacological interventions have failed in clinical trials, meaning that symptom management is the only treatment option. The water channel protein aquaporin-4 (AQP4) is expressed in astrocytes and mediates water flux across the blood-brain and blood-spinal cord barriers. Here we show that AQP4

The intronic SNP rs7903146 in the T-cell factor 7-like 2 gene (TCF7L2) is the common genetic variant most highly associated with Type 2 diabetes known to date. The risk T-allele is located in an open chromatin region specific to human pancreatic islets of Langerhans, thereby accessible for binding of regulatory proteins. The risk T-allele locus exhibits stronger enhancer activity compared to the n

Pancreatic islets are complex micro-organs consisting of at least three different cell types: glucagon-secreting alpha, insulin-producing beta and somatostatin-releasing delta cells. Somatostatin is a powerful paracrine inhibitor of insulin and glucagon secretion. In diabetes, increased somatostatinergic signalling leads to defective counter-regulatory glucagon secretion. This increases the risk o